SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001214659-21-011957
Filing Date
2021-11-17
Accepted
2021-11-17 15:39:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 j1117211sc13ga1.htm SC 13G/A 40281
  Complete submission text file 0001214659-21-011957.txt   41998
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Subject) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90431 | Film No.: 211420488
SIC: 2834 Pharmaceutical Preparations

Mailing Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301
Business Address 228 HAMILTON AVENUE, 3RD FLOOR PALO ALTO CA 94301 650-798-5495
TCG Crossover Management, LLC (Filed by) CIK: 0001839948 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A